Personal tools
Log in

Skip to content. | Skip to navigation

Sections
Document Actions
enGINe Newsletter

Subscribe here to the enGINe Newsletter.

Search
Documents in the library
Positronen-Emissions-Tomograph...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Positronen-Emissions-Tomographie (PET) bei Ovarialkarzinom

Status:
Published
Date of publication:
Mar 27, 2012
Belimumab - Nutzenbewertung ge...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Belimumab - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

Status:
Published
Date of publication:
Apr 26, 2012
Fampridin - Nutzenbewertung ge...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Fampridin - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

Status:
Published
Date of publication:
Apr 26, 2012
Ipilimumab - Nutzenbewertung g...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Ipilimumab - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

Status:
Published
Date of publication:
Apr 27, 2012
Evidence-based care guideline ...

AHRQ (US) - Agency for Healthcare Research and Quality

Evidence-based care guideline for prevention and management of acute gastroenteritis (AGE) in children aged 2 months to 18 years. Cincinnati Children's Hospital Medical Center. NGC:008846

Status:
Published
Date of publication:
Dec 21, 2011
More guidelines
 

Networking with G-I-N

6th G-I-N Conference, Lisboa, November 2009

Evidence translation is different countries

Brief introduction plenary speakers

Alessandro Liberati MD, MPH,

Associate Professor, University of Modena and Reggio Emilia; Director, Italian Cochrane Centre; consultant of the Regional Health and Social Care Agency, Bologna Italy.
Professor Liberati is a member of the GRADE working group and works with guideline developers in Italy and internationally. His areas of interests include methodology of systematic reviews and evaluation of translation of research results into clinical practice. He is co-convenor of the PRISMA working group which produced PRISMA (Preferred Items for Reporting of Systematic Reviews and Metanalyses), a new guidance for reporting of systematic reviews and metanalyses of health care interventions.

Rodrigo Pardo MD, MSc

Neurologist and clinical epidemiologist at the National University in Colombia.

Dr Pardo’s work focuses on the development of clinical guidelines in a developing country. He is leading a regional model working in the Spanish language to help new developers achieve success.

Albertino Damasceno MD, PhD, FESC

Cardiologist, Associate Professor, Eduardo Mondlane University, Maputo, Mozambique. Head, Cardiac Department, Maputo Central Hospital.

Professor Damasceno has been invited to participate in several working groups of WHO, some for the development of guidelines adapted to poorer environments. His areas of interest include hypertension and salt sensitivity, heart failure, stroke and cardiovascular epidemiology.

Françoise Cluzeau, BA, MSc, PhD

Senior Adviser at NICE International, London, England.

Dr Cluzeau is responsible for designing and delivering on guidelines and HTA projects with client countries. For six years she was a technical advisor to the NICE guidelines programme with responsibility for the guidelines manual. She led the AGREE collaboration and she is the chair of the AGREE Research Trust (ART). She is a member of the GRADE group and of the G-I-N Advisory Group. She holds a lectureship at St George’s University of London.

Holger Schünemann, MD, PhD, MSc,

FRCP(C) Chair, Department of Clinical Epidemiology and Biostatistics, Michael Gent Chair in Healthcare Research, Professor of Clinical Epidemiology, Biostatistics and Medicine.

Professor Schünemann is co-chair of the GRADE working group. He works with guideline developers around the world and serves as documents editor for the American Thoracic Society, where he is responsible for overseeing the publication of all official statements of the society, including guidelines.

Robin T. Harbour, BSc

Quality and Information Director, SIGN, Edinburgh, Scotland.

Mr Harbour trained as a librarian, and has worked in a range of scientific and technical organisations. He has an honours degree in biology, as well as various management and language qualifications. He has been involved with information retrieval since the introduction of online computerised information systems in the early 1970s. He is the author of a (now very dated) book on library automation, as well as several articles on literature searching and guideline methodology. Since 1996 he has worked for SIGN, and was responsible for much of the early development of their methodology. His current responsibilities include the development of the systematic review process, and methods used for the grading of recommendations, and quality assurance procedures.

Karen Facey PhD

Honorary Senior Research Fellow in the Department of Public Health and Health Policy at the University of Glasgow and Honorary Member of the Faculty of Public Health in the UK.

Following a career as a statistician in the pharmaceutical sector, Dr Facey has worked for the past nine years in health technology assessment (HTA). She has developed a passion for bringing patient perspectives into the HTA process and since its inception in 2005 has chaired the Interest Group on Patient/Citizen Involvement in HTA for Health Technology Assessment International (HTAi).

Carol Sakala, PhD, MSPH

Director of Programs at Childbirth Connection, of New York City, USA.

Dr Sakala has worked for over 25 years to improve the quality of maternity care, with a continuous focus on the best interests of women and families. She is a public member of the G-I-N Patient and Public Involvement Working Group Steering Committee.

Antoine Boivin, MD, MSc, PhD(c), CCFP

Family physician and a doctoral candidate at the Scientific Institute for Quality of Healthcare in the Netherlands.

Dr Boivin’s research work focuses on the role of patients and the public in health services delivery and quality. He is the scientific content leader for the G-I-N Patient and Public Involvement Working Group.

Liisa-Maria Voipio-Pulkki MD, PhD

Specialist in internal medicine and cardiology.

Currently senior medical adviser, The Association of Finnish Local and Regional Authorities in Helsinki, Finland, and adjunct professor of medicine, University of Turku, Finland. Dr Pulkki’s research interests include clinical and experimental cardiology; organisation of acute health care, continuous professional development and clinical practice guideline implementation.

Heather Buchan, MBChB, FFPHM

Dr Buchan works for the Australian National Health and Medical Research Council, providing advice on the redevelopment of their clinical guidelines programme. She was previously Chief Executive Officer at the National Institute of Clinical Studies, an organisation funded by the Australian government to improve the uptake of best available evidence into current clinical practice. She trained in New Zealand as a public health physician specialising in medical management and became interested in improving uptake of research knowledge while undertaking post-graduate studies in epidemiology as an Oxford Nuffield Medical Scholar.

 

To access the programme and more information on the conference please click here.

 

7th G-I-N Conference, Chicago, August 2010

Chicago ConferenceIntegrating Knowledge. Improving Outcomes.

 

To access more information on the conference please click here.

 

 

 

INAHTA: Summary of the agreement signed between GIN and INAHTA

The International Network of Agencies for Health Technology Assessment (INAHTA) and G-I-N are international organizations who share a common purpose: promoting the appropriate introduction and diffusion of safe, effective, and efficient health care technologies around the world. Although INAHTA and G-I-N have different approaches both believe that their interest in pursuing this common purpose can be achieved more effectively by entering into a partnership. Following discussions between the organisations an agreement was prepared and signed in June of this year. Through this, INHATA and G-I-N agreed to engage cooperative efforts in the pursuit of their objectives.

Page last updated: Jul 28, 2010

Bookmark & Share:

  • Facebook
  • Google Bookmarks
  • Twitter

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.